:: Volume 2, Issue 3 (Journal of Research in Dental & Maxillofacial Sciences summer 2017) ::
J Res Dentomaxillofac Sci 2017, 2(3): 22-30 Back to browse issues page
Clinical Significance of Salivary Biomarkers in Oral Squamous Cell Carcinoma: A Review
M Manzarpour1, M Homaie1, S Farhadi *2
1- Dentist, Islamic Azad University, Tehran, Iran
2- Assistant professor,Oral & Maxillofacial pathology Dept, Dental Branch of Tehran, Islamic Azad University, Tehran, Iran , dr.sfarhadi@gmail.com
Abstract:   (1747 Views)
Background and Aim: Oral squamous cell carcinoma (OSCC) accounts for approximately 3% of all cancers worldwide, and if diagnosed early, it has a five-year survival rate of around 85%; however, a late diagnosis may decrease the survival rate to 50%. Aberrant expression of several genes is associated with the hallmarks of OSCC including uncontrolled cell proliferation, poor differentiation, invasion, metastasis, and angiogenesis. The potential of molecular biomarkers for the diagnosis, prognosis, or monitoring of the treatment efficacy in OSCC has been extensively explored during the last decades. This study aimed to review the significance of salivary biomarkers in the treatment outcome of OSCC.
Materials and Methods: The articles in scientific databases including Google Scholar, ScienceDirect, Medline, and PubMed, published between 2004 and 2017, were searched by using relevant keywords including OSCC, biomarkers, diagnosis, prognosis and treatment outcome. Thirty-four articles were reviewed in this study.
Results: According to the findings of the reviewed studies, several salivary biomarkers including subcutaneous adipose tissue (SAT), interleukin-8 (IL-8), Cyfra 21-1, 8-hydroxy-2-deoxyguanosine, malondialdehyde, lactate dehydrogenase (LDH), Annexin A8, ErbB2, carcinoembryonic antigen (CEA), C-reactive protein (CRP), and salivary proteomic biomarkers might be used as indicators for the detection of oral cancer and premalignant oral disease (PMOD) and as a potential marker in the prognosis of OSCC.
Conclusion: Salivary biomarker analysis seems to be a major advancement in the diagnosis of OSCC, and it is a fast-developing field in scientific research. The results indicate that salivary biomarkers can be useful diagnostic and prognostic tools in OSCC. 
Keywords: Carcinoma, Squamous Cell, Biomarkers, Diagnosis, Prognosis, Treatment Outcome
Full-Text [PDF 1780 kb]   (1225 Downloads) |   |   Full-Text (HTML)  (53 Views)  
Type of Study: Review article | Subject: Oral pathology
* Corresponding Author Address: Islamic Azad University, Tehran, Iran
References
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
2. Int J Cancer. 2015 Mar 1;136(5):E359-86.
3. Attar E, Dey S, Hablas A, Seifeldin IA, Ramadan M, Rozek LS, et al. Head and Neck Cancer in a Developing Country: A Population-Based Perspective Across 8 Years. Oral Oncol. 2010 Aug;46(8):591-6.
4. Bagan J, Sarrion G, Jimenez Y. Oral Cancer: Clinical Features. Oral Oncol. 2010 Jun;46(6):414-7.
5. Abbasi F, Farhadi S, Esmaili M. Efficacy of Pilocarpine and Bromhexine in Improving Radiotherapy-induced Xerostomia. J Dent Res Dent Clin Dent Prospects. 2013;7(2):86-90.
6. Ford PJ, Farah CS. Early detection and diagnosis of oral cancer: Strategies for improvement. J Cancer Policy 2013;Mar–Jun;1(1-2):e2–e7.
7. Shahsavari F, Farhadi S, Sadri D, Sedehi M. Evaluation of Microvascularity by CD34 Expression in Esophagus and Oral Squamous Cell Carcinoma. J Contemp Dent Pract. 2015 Jun 1;16(6):458-62.
8. Sargolzaei S, Farhadi S, Kazemi B, Bandehpour M, Kharazifard MJ. The correlation between p16 expression and INK4a locus mutation with grades and stages in oral squamous cell carcinoma. Indian J Pathol Microbiol. 2014 Jan-Mar;57(1):24-30.
9. Shah FD, Begum R, Vajaria BN, Patel KR, Patel JB, Shukla SN, et al. A review on salivary genomics and proteomics biomarkers in oral cancer. Indian J Clin Biochem. 2011;26(4):326–34.
10. Markopoulos AK, Michailidou EZ, Tzimagiorgis G. Salivary markers for oral cancer
11. detection. Open Dent J. 2010;4:172–8.
12. Bano S, David MP, Indira AP. Salivary Biomarkers for Oral Squamous Cell Carcinoma: An Overview. IJSS Case Reports & Reviews.2015 Jan;1(8):39–45.
13. Cheng YL, Jordan L, Chen HS, Kang D, Oxford L, Plemons J, Parks H, Rees T. Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers. J Periodontal Res. 2017 Jun;52(3):428-37..
14. Chen YT, Chen HW, Wu CF, Chu LJ, Chiang WF, Wu CC, et al. Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers. Mol Cell Proteomics. 2017 May;16(5):799-811.
15. Ohshima M, Sugahara K, Kasahara K, Katakura A. Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma. Oncol Rep. 2017 May;37(5):2727-2734.
16. Sahibzada HA, Khurshid Z, Khan RS, Naseem M, Siddique KM, Mali M, et al. Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer. Diagnostics (Basel). 2017 Apr 9;7(2). pii: E21.
17. Ghallab NA, Shaker OG Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig. 2017 Apr;21(3):937-47.
18. Stuani VT, Rubira CM, Sant'Ana AC, Santos PS. Salivary biomarkers as tools for oral squamous cell carcinoma diagnosis: A systematic review. Head Neck. 2017 Apr;39(4):797-811.
19. Sannam Khan R, Khurshid Z, Akhbar S, Faraz Moin S. Advances of Salivary Proteomics in Oral Squamous Cell Carcinoma (OSCC) Detection: An Update. Proteomes. 2016 Dec 15;4(4). pii: E41.
20. Radhika T, Jeddy N, Nithya S, Muthumeenakshi RM.Salivary biomarkers in oral squamous cell carcinoma – An insight. J Oral Biol Craniofac Res. 2016 Nov; 6(Suppl 1): S51–S54.
21. Michailidou E, Tzimagiorgis G, Chatzopoulou F, Vahtsevanos K, Antoniadis K, Kouidou S, et al. Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia. Cancer Epidemiol. 2016 Aug;43:112-8.
22. Gleber-Netto FO, Yakob M, Li F, Feng Z, Dai J, Kao HK, et al. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.Clin Cancer Res. 2016 Jul 1;22(13):3340-7.
23. Malhotra R, Urs AB, Chakravarti A, Kumar S, Gupta VK, Mahajan B. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma. Tumour Biol. 2016 Jul;37(7):9263-71.
24. Jacob TV, Ramesh M, Murali S, Ramesh K, Sanjay PR, Abraham P. A non-invasive study to estimate and compare salivary sialic acid level as tumor marker in patients with pre-cancer and oral cancer. J Cancer Res Ther. 2016 Apr-Jun;12(2):634-9.
25. Santosh AB, Jones T, Harvey J. A review on oral cancer biomarkers: Understanding the past and learning from the present. J Cancer Res Ther. 2016 Apr-Jun;12(2):486-92.
26. Kaur J, Politis C, Jacobs R. Response on: Comments on "Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action". Clin Oral Investig. 2016 Mar;20(2):397.
27. Lokesh K, Kannabiran J, Rao MD. Salivary Lactate Dehydrogenase (LDH)- A Novel Technique in Oral Cancer Detection and Diagnosis. J Clin Diagn Res. 2016 Feb;10(2):ZC34-7.
28. Oka R, Nakashiro K, Goda H, Iwamoto K, Tokuzen N, Hamakawa H. Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma. Oncotarget. 2016 Jan 26;7(4):4882-9.
29. Honarmand MH, Farhad-Mollashahi L, Nakhaee A, Nehi M. Salivary Levels of ErbB2 and CEA in Oral Squamous Cell Carcinoma Patients. Asian Pac J Cancer Prev. 2016;17(S3):77-80.
30. Metgud R, Bajaj S.Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma. Biotech Histochem. 2016;91(2):96-101.
31. Gallo C, Ciavarella D, Santarelli A, Ranieri E, Colella G, Lo Muzio L, et al.Potential Salivary Proteomic Markers of Oral Squamous Cell Carcinoma. Cancer Genomics Proteomics. 2016 Jan-Feb;13(1):55-61.
32. Winck FV, Prado Ribeiro AC, Ramos Domingues R, Ling LY, Riaño-Pachón DM, Rivera C, et al . Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Sci Rep. 2015 Nov; 5;5:16305.
33. Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C.Salivary microRNAs in oral cancer. Oral Dis. 2015 Sep;21(6):739-47.
34. Rajkumar K, Ramya R, Nandhini G, Rajashree P, Ramesh Kumar A, Nirmala Anandan S.Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma. Oral Dis. 2015 Jan;21(1):90-6.
35. Aziz S, Ahmed SS, Ali A, Khan FA, Zulfiqar G, Iqbal J, Khan AA, Shoaib M. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients. Cancer Invest. 2015;33(7):318-28.
36. Wang Q, Gao P, Wang X, Duan Y. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin Chim Acta. 2014 Jan 1;427:79-85.
37. Panta P, Venna VR. Salivary RNA signatures in oral cancer detection. Anal Cell Pathol (Amst). 2014;2014:450629.
38. Wu CC, Chang YT, Chang KP, Liu YL, Liu HP, Lee IL, et al. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1569-78.
39. Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J,et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol. 2011 Jan;47(1):51-5.
40. Tang H, Wu Z, Zhang J, Su B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis .Mol Med Rep. 2013 Mar;7(3):761-6.
41. Fuchs PN, Rogić D, Vidović-Juras D, Susić M, Milenović A, Brailo V, et al. Salivary analytes in patients with oral squamous cell carcinoma. Coll Antropol. 2011 Jun;35(2):359-62.
42. Jou YJ, Lin CD, Lai CH, Tang CH, Huang SH, Tsai MH, et al. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Clin Chim Acta. 2011 Jul 15;412(15-16):1357-65.
43. Stott-Miller M, Houck JR, Lohavanichbutr P, Méndez E, Upton MP, Futran ND,et al. Tumor and salivary matrixmetalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2628-36.
44. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J,et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008 Oct 1;14(19):6246-52.
45. Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers--a new diagnostic tool for oral cancer. Clin Cancer Res. 2006 Jul 1;12(13):3979-84.
46. Li Y, St John MA, Zhou X, Kim Y, Sinha U, JordanRC,et al.Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004 Dec 15;10(24):8442-50.
47. Spielmann N, Wong DT. Saliva-diagnostics and therapeutic perspectives. Oral Dis. 2011;17(4):345–54.
48. Mishra A, Verma M. Cancer biomarkers: are we ready for the prime time? Cancers (Basel).2010 Mar 22;2(1):190-208.
49. Tanaka T, Tanaka M, Tanaka T. Oral carcinogenesis and oral cancer chemoprevention: a review Pathol Res Int. 2011;2011:431246.
50. Yoshizawa JM, Schafer CA, Schafer JJ, Farrell JJ, Paster BJ, Wong DT. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev. 2013 Oct;26(4):781-91.
51. Cheng YS, Rees T, Wright J. A review of research on salivary biomarkers for oral cancer detection. Clin Transl Med. 2014 Feb 24;3(1):3.



XML     Print



Volume 2, Issue 3 (Journal of Research in Dental & Maxillofacial Sciences summer 2017) Back to browse issues page